Craniometrix delivers AI-driven care navigation for dementia patients, integrating MIND at Home clinical models and specialty-trained navigators. The platform supports comprehensive assessments, personalized care planning, and 24/7 caregiver support. It enables providers to meet Medicare's GUIDE requirements and generate new revenue through patient care programs.
CEO
CTO
Craniometrix primarily focuses on the healthcare industry, specifically in providing innovative dementia care solutions through the use of AI-powered navigation software to enhance patient outcomes and support healthcare providers.
Revenue from Medicare's GUIDE Model; supports dementia care through insurance reimbursement.
Craniometrix operates in the dementia care solutions market, where its main competitors include:
Fives Lives: Founded in 2019, this London-based company focuses on risk detection and prevention of dementia. It has raised $3.82 million in funding, positioning it as a more established player compared to Craniometrix, which has raised $125K. Fives Lives emphasizes a proactive approach to dementia care.
Memory Lane Games: Established in 2013 in the UK, this company offers a digital health app aimed at dementia management through gamification. Although currently unfunded, its unique approach may attract a different demographic than Craniometrix's AI-driven self-assessment platform.
RecallCue: Founded in 2017 in Israel, RecallCue provides a mobile app designed to assist seniors with dementia. Like Memory Lane Games, it is unfunded, which may limit its growth potential. RecallCue focuses on practical assistance for seniors rather than predictive analytics.
Craniometrix's notable advantage lies in its use of artificial intelligence to predict the likelihood of developing Alzheimer's disease, offering tailored health reports based on various health data points. This predictive approach differentiates it from competitors that primarily focus on management and prevention.